Ultralife (NASDAQ:ULBI) Director Bradford Whitmore Purchases 29,766 Shares of Stock

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore acquired 29,766 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were bought at an average cost of $6.63 per share, with a total value of $197,348.58. Following the completion of the acquisition, the director directly owned 1,128,731 shares in the company, valued at $7,483,486.53. The trade was a 2.71% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Ultralife Trading Up 0.9%

NASDAQ ULBI opened at $6.66 on Friday. The company has a quick ratio of 1.62, a current ratio of 3.31 and a debt-to-equity ratio of 0.34. The stock’s 50-day simple moving average is $8.09 and its two-hundred day simple moving average is $6.57. Ultralife Corporation has a twelve month low of $4.07 and a twelve month high of $11.48. The company has a market capitalization of $110.82 million, a price-to-earnings ratio of 35.05 and a beta of 1.00.

Ultralife (NASDAQ:ULBI) last announced its quarterly earnings data on Thursday, August 7th. The technology company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.07). The firm had revenue of $48.56 million for the quarter, compared to the consensus estimate of $51.00 million. Ultralife had a net margin of 1.79% and a return on equity of 2.68%.

Institutional Investors Weigh In On Ultralife

Several institutional investors have recently added to or reduced their stakes in the company. Nuveen Asset Management LLC increased its position in shares of Ultralife by 59.1% in the fourth quarter. Nuveen Asset Management LLC now owns 21,647 shares of the technology company’s stock valued at $161,000 after acquiring an additional 8,037 shares during the period. IFP Advisors Inc increased its holdings in Ultralife by 24.6% during the 1st quarter. IFP Advisors Inc now owns 14,200 shares of the technology company’s stock valued at $76,000 after purchasing an additional 2,800 shares during the period. Squarepoint Ops LLC raised its position in Ultralife by 47.1% during the 4th quarter. Squarepoint Ops LLC now owns 42,261 shares of the technology company’s stock valued at $315,000 after purchasing an additional 13,538 shares during the last quarter. Northern Trust Corp lifted its holdings in Ultralife by 8.0% in the 4th quarter. Northern Trust Corp now owns 87,633 shares of the technology company’s stock worth $653,000 after buying an additional 6,484 shares during the period. Finally, Barclays PLC grew its position in shares of Ultralife by 13.7% in the 4th quarter. Barclays PLC now owns 15,233 shares of the technology company’s stock worth $113,000 after buying an additional 1,838 shares during the last quarter. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Ultralife from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 6th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Ultralife currently has a consensus rating of “Buy” and a consensus price target of $14.00.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.